Mark H Eckman

Summary

Affiliation: University of Cincinnati
Country: USA

Publications

  1. doi request reprint Cost-effectiveness of screening for chronic hepatitis C infection in the United States
    Mark H Eckman
    Division of General Internal Medicine and the Center for Clinical Effectiveness, OH, USA
    Clin Infect Dis 56:1382-93. 2013
  2. doi request reprint Impact of health literacy on outcomes and effectiveness of an educational intervention in patients with chronic diseases
    Mark H Eckman
    Division of General Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA
    Patient Educ Couns 87:143-51. 2012
  3. ncbi request reprint Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis
    Mark H Eckman
    Division of General Internal Medicine, Center for Clinical Effectiveness, University of Cincinnati, OH 45267 0535, USA
    Med Decis Making 22:108-24. 2002
  4. ncbi request reprint Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation
    Mark H Eckman
    University of Cincinnati Medical Center, Cincinnati, OH 45267 0535, USA
    Ann Intern Med 150:73-83. 2009
  5. ncbi request reprint "Bridging on the river Kwai": the perioperative management of anticoagulation therapy
    Mark H Eckman
    Division of General Internal Medicine and Center for Clinical Effectiveness, University of Cincinnati, Cincinnati, OH 45267 0557, USA
    Med Decis Making 25:370-3. 2005
  6. pmc Should we test for CYP2C9 before initiating anticoagulant therapy in patients with atrial fibrillation?
    Mark H Eckman
    Division of General Internal Medicine and Center for Clinical Effectiveness, University of Cincinnati Medical Center, University of Cincinnati MHE, PO Box 670535, Cincinnati, OH 45267 0535, USA
    J Gen Intern Med 24:543-9. 2009
  7. doi request reprint Longitudinal analysis of genitourinary and bowel symptoms in prostate cancer patients following brachytherapy
    Mark H Eckman
    Division of General Internal Medicine, Department of Medicine, and Center for Clinical Effectiveness, Cincinnati, Ohio, USA
    Am J Clin Oncol 33:1-10. 2010
  8. doi request reprint Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help?
    Mark H Eckman
    Division of General Internal Medicine and the Center for Clinical Effectiveness, University of Cincinnati Medical Center, Cincinnati, Ohio 45267 0535, USA
    Stroke 39:3308-15. 2008
  9. pmc Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation
    Mark H Eckman
    Division of General Internal Medicine and the Center for Clinical Effectiveness, University of Cincinnati, Cincinnati, OH 45267 0535, USA
    Circ Cardiovasc Qual Outcomes 4:14-21. 2011
  10. ncbi request reprint Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis
    Mark H Eckman
    Division of General Internal Medicine and the Center for Clinical Effectiveness, University of Cincinnati, Cincinnati, OH, USA
    Stroke 34:1710-6. 2003

Detail Information

Publications39

  1. doi request reprint Cost-effectiveness of screening for chronic hepatitis C infection in the United States
    Mark H Eckman
    Division of General Internal Medicine and the Center for Clinical Effectiveness, OH, USA
    Clin Infect Dis 56:1382-93. 2013
    ..Our objective was to develop decision analytic models to explore the cost-effectiveness of screening in populations with varying prevalence of HCV and risks for fibrosis progression...
  2. doi request reprint Impact of health literacy on outcomes and effectiveness of an educational intervention in patients with chronic diseases
    Mark H Eckman
    Division of General Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA
    Patient Educ Couns 87:143-51. 2012
    ..Study impact of health literacy on educational intervention for patients "Living with Coronary Artery Disease."..
  3. ncbi request reprint Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis
    Mark H Eckman
    Division of General Internal Medicine, Center for Clinical Effectiveness, University of Cincinnati, OH 45267 0535, USA
    Med Decis Making 22:108-24. 2002
    ..Survivors of venous thromboembolism who have the factor V Leiden mutation have an increased risk of recurrent venous thromboembolism (VTE), but the cost-effectiveness of testing for factor VLeiden has not been assessed...
  4. ncbi request reprint Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation
    Mark H Eckman
    University of Cincinnati Medical Center, Cincinnati, OH 45267 0535, USA
    Ann Intern Med 150:73-83. 2009
    ..In 2007, the U.S. Food and Drug Administration changed the labeling for warfarin (Coumadin, Bristol-Myers Squibb, Princeton, New Jersey), suggesting that clinicians consider genetic testing before initiating therapy...
  5. ncbi request reprint "Bridging on the river Kwai": the perioperative management of anticoagulation therapy
    Mark H Eckman
    Division of General Internal Medicine and Center for Clinical Effectiveness, University of Cincinnati, Cincinnati, OH 45267 0557, USA
    Med Decis Making 25:370-3. 2005
  6. pmc Should we test for CYP2C9 before initiating anticoagulant therapy in patients with atrial fibrillation?
    Mark H Eckman
    Division of General Internal Medicine and Center for Clinical Effectiveness, University of Cincinnati Medical Center, University of Cincinnati MHE, PO Box 670535, Cincinnati, OH 45267 0535, USA
    J Gen Intern Med 24:543-9. 2009
    ..Genetic variants of the warfarin sensitivity gene CYP2C9 have been associated with increased bleeding risk during warfarin initiation. Studies also suggest that such patients remain at risk throughout treatment...
  7. doi request reprint Longitudinal analysis of genitourinary and bowel symptoms in prostate cancer patients following brachytherapy
    Mark H Eckman
    Division of General Internal Medicine, Department of Medicine, and Center for Clinical Effectiveness, Cincinnati, Ohio, USA
    Am J Clin Oncol 33:1-10. 2010
    ..We present a descriptive, longitudinal analysis of genitourinary and bowel symptoms following treatment in a brachytherapy registry at the University of Cincinnati...
  8. doi request reprint Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help?
    Mark H Eckman
    Division of General Internal Medicine and the Center for Clinical Effectiveness, University of Cincinnati Medical Center, Cincinnati, Ohio 45267 0535, USA
    Stroke 39:3308-15. 2008
    ..We explore whether screening strategies that include genetic profiling and neuroimaging might improve the safety of chronic anticoagulation for atrial fibrillation by identifying individuals from whom warfarin should be withheld...
  9. pmc Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation
    Mark H Eckman
    Division of General Internal Medicine and the Center for Clinical Effectiveness, University of Cincinnati, Cincinnati, OH 45267 0535, USA
    Circ Cardiovasc Qual Outcomes 4:14-21. 2011
    ..Furthermore, new and potentially safer anticoagulants are on the horizon. Thus, the balance between risk factors for stroke and benefit of anticoagulation may be shifting...
  10. ncbi request reprint Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis
    Mark H Eckman
    Division of General Internal Medicine and the Center for Clinical Effectiveness, University of Cincinnati, Cincinnati, OH, USA
    Stroke 34:1710-6. 2003
    ....
  11. pmc The cost-effectiveness of screening for chronic hepatitis B infection in the United States
    Mark H Eckman
    Division of General Internal Medicine and the Center for Clinical Effectiveness, Ohio, USA
    Clin Infect Dis 52:1294-306. 2011
    ..Our objective was to determine whether this screening threshold is cost-effective and whether screening lower-prevalence populations might also be cost-effective...
  12. pmc Valuation of scleroderma and psoriatic arthritis health states by the general public
    Dinesh Khanna
    Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA
    Health Qual Life Outcomes 8:112. 2010
    ..Our objective was to assess health values (utilities) from the general public for health states common to people with PsA and SSc for economic evaluations...
  13. pmc Application of a decision support tool for anticoagulation in patients with non-valvular atrial fibrillation
    Mark L Wess
    Division of General Internal Medicine, University of Cincinnati Medical Center, Cincinnati, OH 45267 0535, USA
    J Gen Intern Med 23:411-7. 2008
    ..The use of a patient-specific computerized decision support tool may aid in closing the knowledge gap regarding the best treatment for a patient...
  14. ncbi request reprint Predictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillation
    Joseph A Johnston
    Veterans Affairs Medical Center, Division of General Internal Medicine, University of Cincinnati Medical Center, University of Cincinnati, Cincinnati, Ohio 45267, USA
    Arch Intern Med 163:1705-10. 2003
    ..Despite demonstrated efficacy in stroke prevention, warfarin is underused in patients with atrial fibrillation (AF). Reasons for warfarin nonuse are unclear...
  15. ncbi request reprint Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism
    Joseph A Johnston
    The Health Services Research and Development Service, Veterans Affairs Medical Center, Cincinnati, Ohio, USA
    Am J Med 118:503-14. 2005
    ..The balance of risks and benefits in women with different recurrence risks has not been examined...
  16. doi request reprint Thiopurine S- methyltransferase [corrected] testing in idiopathic pulmonary fibrosis: a pharmacogenetic cost-effectiveness analysis
    Jared T Hagaman
    Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati, 231 Albert Sabin Way ML 0564, Cincinnati, OH 45267, USA
    Lung 188:125-32. 2010
    ..At prevalence rates lower than our base case, it was not. TPMT testing before initiating therapy with azathioprine, NAC, and steroids is a cost-effective treatment strategy for IPF...
  17. ncbi request reprint Patient-specific decision modeling to guide the use of drotrecogin alpha (activated) in patients with severe sepsis
    Daniel P Schauer
    Division of General Internal Medicine, University of Cincinnati Medical Center, Cincinnati, OH 45267 0535, USA
    J Crit Care 23:484-92. 2008
    ..Our objective was to create a decision support tool incorporating patient-specific inputs to estimate the balance between treatment risks and benefits for individual patients with severe sepsis...
  18. ncbi request reprint Racial disparities in the filling of warfarin prescriptions for nonvalvular atrial fibrillation
    Daniel P Schauer
    Division of General Internal Medicine, Institute for the Study of Health, University of Cincinnati Medical Center, Cincinnati, Ohio 45267 0535, USA
    Am J Med Sci 333:67-73. 2007
    ..Our goal was to establish whether there have been racial disparities in the filling of warfarin prescriptions for patients with newly incident nonvalvular atrial fibrillation...
  19. pmc Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin
    Daniel P Schauer
    Division of General Internal Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio 45267 0535, USA
    J Gen Intern Med 20:1114-9. 2005
    ....
  20. ncbi request reprint Use of regression modeling to simulate patient-specific decision analysis for patients with nonvalvular atrial fibrillation
    Joseph A Johnston
    University of Cincinnati Medical Center, Ohio, USA
    Med Decis Making 23:361-8. 2003
    ..To create a Web-based decision support tool that uses a simple regression equation to simulate performance of patient-specific decision analysis (PSDA) for patients with nonvalvular atrial fibrillation...
  21. pmc A randomized study of scleroderma health state values: a picture is worth a thousand words, and quite a few utiles. [corrected]
    Dinesh Khanna
    Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA
    Med Decis Making 29:7-14. 2009
    ..We assess utilities from the general public for health states common in scleroderma (SSc) by describing the health states in writing alone v. with photographs of patients with SSc...
  22. pmc Decision modeling to estimate the impact of gastric bypass surgery on life expectancy for the treatment of morbid obesity
    Daniel P Schauer
    University of Cincinnati Medical Center, Medical Center, Cincinnati, OH 45267 0535, USA
    Arch Surg 145:57-62. 2010
    ..To create a decision analytic model to estimate the balance between treatment risks and benefits for patients with morbid obesity...
  23. doi request reprint Cost-effectiveness analysis of ED decision making in patients with non-high-risk heart failure
    Sean P Collins
    Department of Emergency Medicine, University of Cincinnati, Cincinnati, OH 45267, USA
    Am J Emerg Med 27:293-302. 2009
    ..The ED disposition of patients with non-high-risk acute decompensated heart failure (ADHF) is challenging. To help address this problem, we investigated the cost-effectiveness of different ED disposition strategies...
  24. pmc Predictors of bariatric surgery among an interested population
    Daniel P Schauer
    Division of General Internal Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio Electronic address
    Surg Obes Relat Dis 10:547-52. 2014
    ..The objectives of this study was to study the forces driving this decision and improve our understanding of the decision-making process...
  25. doi request reprint Understanding preferences for disclosure of individual biomarker results among participants in a longitudinal birth cohort
    Stephen E Wilson
    Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio, USA
    J Med Ethics 36:736-40. 2010
    ..To describe the preferences for disclosure of individual biomarker results among mothers participating in a longitudinal birth cohort...
  26. ncbi request reprint Screening for the risk for bleeding or thrombosis
    Mark H Eckman
    Division of General Internal Medicine, University of Cincinnati Medical Center, PO Box 670535, 231 Albert Sabin Way, Cincinnati, OH 45267 0535, USA
    Ann Intern Med 138:W15-24. 2003
    ..Appropriate use of these tests must involve consideration of the clinical setting, disease prevalence, performance characteristics of the tests, cost, and consequences of false-positive and false-negative results...
  27. doi request reprint Cost-effectiveness of telemetry for hospitalized patients with low-risk chest pain
    Michael J Ward
    Department of Emergency Medicine, University of Cincinnati, Cincinnati, OH, USA
    Acad Emerg Med 18:279-86. 2011
    ..Despite a low incidence of cardiac events, limited telemetry availability, and its questionable benefit, these patients are routinely admitted to a monitored setting...
  28. doi request reprint Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers
    Marie A de Perio
    Division of Infectious Diseases, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Box 670560, Cincinnati, OH 45267, USA
    Arch Intern Med 169:179-87. 2009
    ..We compared the cost-effectiveness of the QFT-G, QFT-GIT, and TST for detecting LTBI in new health care workers (HCWs)...
  29. doi request reprint Usability of an atrial fibrillation anticoagulation decision-support tool
    Mark L Wess
    Division of General Internal Medicine, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    J Prim Care Community Health 2:100-6. 2011
    ..Treatment decisions frequently are inconsistent with guidelines. A new web-based atrial fibrillation decision-support tool (AF-DST) provides patient-specific information on the risk-benefit tradeoff of anticoagulation...
  30. doi request reprint Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease: a decision analysis
    Alberto J Espay
    Department of Neurology, Movement Disorders Center, The Neuroscience Institute, University of Cincinnati, Cincinnati, Ohio 45267 0525, USA
    Mov Disord 25:1456-63. 2010
    ..These findings support further evaluation of early STN DBS in a controlled clinical trial...
  31. ncbi request reprint Health values of adolescents with cystic fibrosis
    Michael S Yi
    Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati Children s Hospital, Cincinnati Ohio 45267 0535, USA
    J Pediatr 142:133-40. 2003
    ..To assess health values (utilities) in adolescents with cystic fibrosis (CF) and to evaluate how health status and clinical factors affect their health values...
  32. pmc Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage
    Brett M Kissela
    Department of Neurology, University of Cincinnati, 260 Stetson Street, Suite 2300, Cincinnati, Ohio 45267 05525, USA
    BMC Neurol 8:17. 2008
    ..We hypothesized that rFVIIa would have a low marginal cost-effectiveness ratio (mCER) given the poor neurologic outcomes after ICH with conventional management...
  33. ncbi request reprint Underuse of controller medications among children with persistent asthma in the Ohio medicaid population: evolving differences with new medications
    Stephen E Wilson
    Division of General Internal Medicine, Department of Internal Medicine, College of Medicine, University of Cincinnati, Ohio, USA
    Ambul Pediatr 5:83-9. 2005
    ..Despite innovations in asthma care, morbidity and mortality have increased significantly. Underuse of controller medications is a major contributor to increased morbidity and mortality...
  34. doi request reprint Outcomes of hemodialysis patients in a long-term care hospital setting: a single-center study
    Charuhas V Thakar
    Cincinnati VA Medical Center, Cincinnati, OH, USA
    Am J Kidney Dis 55:300-6. 2010
    ..Outcomes of hemodialysis patients admitted to LTCHs, which includes patients with either end-stage renal disease (ESRD) or acute kidney injury (AKI) requiring dialysis therapy, are not known...
  35. ncbi request reprint The impact of expected HIV transmission rates on the effectiveness and cost of ruling out HIV infection in infants
    Joseph M Mrus
    Division of General Internal Medicine, University of Cincinnati Medical Center, P O Box 670535, Cincinnati, OH 45267 0535, USA
    Med Decis Making 22:S38-44. 2002
    ..To quantify the costs and effectiveness of different strategies for ruling out HIV infection in infants born to HIV-infected mothers in the United States...
  36. ncbi request reprint Provisional vs. complex stenting strategy for coronary bifurcation lesions: meta-analysis of randomized trials
    Abdul Hakeem
    Division of Cardiovascular Diseases, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
    J Invasive Cardiol 21:589-95. 2009
    ..To assess the optimal percutaneous coronary intervention (PCI) approach for coronary artery bifurcation lesions (CBL), we conducted a meta-analysis of randomized trials comparing provisional stenting (PS) to complex stenting strategy (CS)...
  37. ncbi request reprint The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage
    Jonathan Rosand
    Neurology Clinical Trials Unit, Department of Neurology, Massachusetts General Hospital, 15 Parkman Street, Boston, MA 02114, USA
    Arch Intern Med 164:880-4. 2004
    ..We studied the determinants of ICH outcome to quantify the independent effect of warfarin...
  38. ncbi request reprint Radioiodine or surgery for toxic thyroid adenoma: dissecting an important decision. A cost-effectiveness analysis
    Gwenaelle M Vidal-Trecan
    Departement de sante publique, CHU Cochin Port Royal, Assistance Publique Hopitaux de Paris, Universite Rene Descartes, Paris, France
    Thyroid 14:933-45. 2004
    ..To examine the cost effectiveness of therapeutic strategies for toxic thyroid adenoma...
  39. ncbi request reprint Presidential reflections on the 25th anniversary of the society for medical decision making
    Arthur S Elstein
    Department of Medical Education, University of Illinois at Chicago, USA
    Med Decis Making 24:408-20. 2004